Engystol
FDA Label NDC 62795-9490

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Medinatura Inc for the product Engystol (NDC 62795-9490). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding indications & usage section, directions, warnings:, active ingredients:, inactive ingredients:, purpose, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Indications & Usage Section

For immune support when experiencing
minor cold & flu symptoms: Body aches, Fatigue,
Headache, Nausea.

Directions

Adults and children 4 years and
older: 1-2 tablets 3 times per day or as directed by a
health practitioner. Not to exceed 6 tablets per 24
hours. Children under 4, as directed by a health
professional. Allow to completely dissolve in the mouth.

Warnings:

 If pregnant or breast-feeding, ask a
health professional before use. Keep out of reach of
children. If symptoms persist or worsen, a healthcare
provider should be consulted. Do not use if known
sensitivity to Engystol® or any of its ingredients exists.

Active Ingredients:

 Each 300 mg tablet contains:
*Asclepias vincetoxicum 6X, 10X, 30X 75mg each;
*Sulphur 4X, 10X 37.5mg each. *Natural

Inactive Ingredients:

 Lactose, Magnesium stearate

Purpose

Immune
Support

Keep Out Of Reach Of Children

KEEP OUT OF REACH OF CHILDREN

* Please review the disclaimer below.